Literature DB >> 15777573

Management of patients with hepatitis B virus-induced cirrhosis.

Scott K Fung1, Anna S F Lok.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15777573     DOI： 10.1016/j.jhep.2004.11.014

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  10 in total

1.  Methylation of Dickkopf-3 as a prognostic factor in cirrhosis-related hepatocellular carcinoma.

Authors:  Bin Yang; Zhi Du; Ying-Tang Gao; Cheng Lou; Shi-Guang Zhang; Tong Bai; Yi-Jun Wang; Wen-Qin Song
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

Review 2.  Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection.

Authors:  Lu Lun-Gen
Journal:  J Clin Transl Hepatol       Date:  2014-09-15

3.  High dose of Lamivudine and resistance in patients with chronic hepatitis B.

Authors:  Hamid Ullah Wani; Saad Al Kaabi; Manik Sharma; Rajvir Singh; Anil John; Moutaz Derbala; Muneera J Al-Mohannadi
Journal:  Hepat Res Treat       Date:  2014-09-30

4.  Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy.

Authors:  Yeon Seok Seo; Mi Na Kim; Seung Up Kim; Sang Gyune Kim; Soon Ho Um; Kwang-Hyub Han; Young Seok Kim
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

5.  Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma.

Authors:  Xueyan Dong; Qiang Hou; Yueming Chen; Xianjun Wang
Journal:  Dis Markers       Date:  2017-08-29       Impact factor: 3.434

6.  TIPE‑2 suppresses growth and aggressiveness of hepatocellular carcinoma cells through downregulation of the phosphoinositide 3‑kinase/AKT signaling pathway.

Authors:  Lin Wang; Chen Chen; Shuzhi Feng; Jianli Tian
Journal:  Mol Med Rep       Date:  2018-03-20       Impact factor: 2.952

7.  Association of GSTP1 and P16 promoter methylation with the risk of HBV-related hepatocellular carcinoma: a meta-analysis.

Authors:  Qin Li; Cunliang Deng; Ting Zhang; Xiang Li
Journal:  Onco Targets Ther       Date:  2018-09-12       Impact factor: 4.345

8.  Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.

Authors:  Seung Up Kim; Ji Hoon Lee; Do Young Kim; Sang Hoon Ahn; Kyu Sik Jung; Eun Hee Choi; Young Nyun Park; Kwang-Hyub Han; Chae Yoon Chon; Jun Yong Park
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

9.  Inhibition of hepatocellular carcinoma growth by adenovirus-mediated expression of human telomerase reverse transcriptase COOH-27 terminal polypeptide in mice.

Authors:  Lei He; Han-Xian Gong; Xiang-Pen Li; Yi-Dong Wang; Yi Li; Jun-Jian Huang; Dan Xie; Hsiang-Fu Kung; Ying Peng
Journal:  Oncol Lett       Date:  2013-07-16       Impact factor: 2.967

10.  Combination therapy of hTERTR and FAM96A for hepatocellular carcinoma through enhancing apoptosis sensitivity.

Authors:  Wan-Peng Wang; Hai-Ying Gao
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.